Glenmark Pharmaceuticals consolidated net profit rises 1.08% in the September 2022 quarter

Sales rise 5.99% to Rs 3312.49 crore

Net profit of Glenmark Pharmaceuticals rose 1.08% to Rs 260.44 crore in the quarter ended September 2022 as against Rs 257.66 crore during the previous quarter ended September 2021. Sales rose 5.99% to Rs 3312.49 crore in the quarter ended September 2022 as against Rs 3125.43 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales3312.493125.43 6 OPM %18.7618.88 -PBDT635.92508.15 25 PBT480.21384.96 25 NP260.44257.66 1

Powered by Capital Market - Live News